News Release

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Kyowa Hakko Kirin News Releases 2011

December 7, 2011
English version of the "Kyowa Hakko Kirin Group CSR Report 2011" has been issued
December 5, 2011
Launch of gastrointestinal prokinetic agents:
NAUZELIN® OD Tablets 5 and NAUZELIN® OD Tablets 10
December 1, 2011
Notice regarding status of repurchase of own sharesPDF file:New window opens(76KB)
November 16, 2011
Fujifilm and Kyowa Hakko Kirin to set up a joint venture for the development of biosimilars
November 15, 2011
Launch of Allelock 0.5% Granules for the Treatment of Allergic Symptoms - New Dosage Form
November 1, 2011
Notice regarding status of repurchase of own sharesPDF file:New window opens(52KB)
October 27, 2011
Kyowa Hakko Kirin Q3 (9 months) Operating Profit up 15.8%PDF file:New window opens(40KB)
October 27, 2011
Consolidated Financial Summary Third Quarter of Fiscal 2011PDF file:New window opens(148KB)
October 27, 2011
Appendix to the Fiscal 2011 Third Quarter Consolidated Financial StatementsPDF file:New window opens(140KB)
October 3, 2011
Notice regarding status of repurchase of own sharesPDF file:New window opens(48KB)
September 2, 2011
Notice regarding status of repurchase of own sharesPDF file:New window opens(52KB)
August 25, 2011
Kyowa Hakko Kirin announces decision to repurchase own sharesPDF file:New window opens(36KB)
August 10, 2011
Kyowa Hakko Kirin Additional Indication Application for Synthesized Penicillin "PASETOCIN®"
August 9, 2011
Kyowa Hakko Kirin Announces Commencement of
Phase 3 International Clinical Study of ARQ 197 (Tivantinib) in Patients with
Non-Small Cell Lung Cancer in Asia
August 2, 2011
Kyowa Hakko Kirin
Fiscal 2011 Interim Results Presentation (January 1- June 30, 2011)
PDF file:New window opens(640KB)
August 2, 2011
Consolidated Financial Summary Fiscal 2011 InterimPDF file:New window opens(128KB)
August 2, 2011
Appendix to the Fiscal 2011 Interim Consolidated Financial StatementsPDF file:New window opens(124KB)
August 2, 2011
Kyowa Hakko Kirin Announces Strong Growth in First Half ProfitsPDF file:New window opens(40KB)
July 26, 2011
Kyowa Hakko Kirin Submitted New Drug Application in Japan for KW-6500
(Apomorphine Hydrochloride Hydrate)
July 20, 2011
Kyowa Hakko Kirin Revises ForecastsPDF file:New window opens(148KB)
June 29, 2011
Kyowa Hakko Kirin announces a Commencement of Phase 3 Clinical Study for KW-3357 in Japan
June 29, 2011
Kyowa Hakko Kirin Announces a Plan to Build a New Pharmaceutical Plant
June 16, 2011
Approval of Additional Indication, Dosage and Administration of Depakene for suppressing the Onset of Migraine Attacks
June 3, 2011
Termination of the North American licensing agreement for KW-6002 (Istradefylline)
June 1, 2011
Ferring and Kyowa Hakko Kirin announce
co-promotion of Desmopressin acetate hydrate orally disintegrating tablet
May 12, 2011
Kyowa Hakko Bio announces the commencement of
commercial production of cis-4-Hydroxy-L-proline
May 10, 2011
Kyowa Hakko Kirin Announces Results of Phase lll Clinical Study of
KW-6002 (Istradefylline) for Parkinson's Disease in Japan
May 10, 2011
New in vitro diagnostic reagents and analyzer for various allergens
Launch announcement for Allerport® HRT and its dedicated analyzer, the Allerport HRT System
May 2, 2011
Notice of revisions to the Appendix to the Fiscal 2011 First Quarter Consolidated Financial StatementsPDF file:New window opens(148KB)
April 27, 2011
Consolidated Financial Summary: First Quarter of the Fiscal Year to December 2011PDF file:New window opens(120KB)
April 27, 2011
(Revised Edition) Appendix to the Fiscal 2011 First Quarter Consolidated Financial StatementsPDF file:New window opens(136KB)
April 27, 2011
Kyowa Hakko Kirin Announces Q1 Growth in Sales, Profits and Net IncomePDF file:New window opens(48KB)
April 26, 2011
Kyowa Hakko Kirin submitted New Drug Application in Japan for KW-0761,
a Therapeutic Antibody for Adult T-cell Leukemia-Lymphoma (ATL)
April 26, 2011
Kyowa Medex Submitted New Drug Application for
In Vitro Diagnostic Reagent to Detect CCR4 Proteins in Japan
April 20, 2011
Kyowa Medex forms a joint business with Toyobo,
for fully automated gene analysis system GENECUBE®
April 13, 2011
Launch of ROMIPLATE® [250 mcg] for subcutaneous injection
- Platelet producer stimulating thrombopoietin receptors for treatment of chronic
Idiopathic Thrombocytopenic Purpura
March 23, 2011
Regarding the effects of the Tohoku Pacific Coast Earthquake (2nd release)PDF file:New window opens(16KB)
March 14, 2011
Regarding the effects of the Tohoku Pacific Coast EarthquakePDF file:New window opens(16KB)
February 9, 2011
Notice of revisions to the financial summary press release Kyowa Hakko Kirin Fiscal 2010 Sales up 1.7%, Operating income up 46.8%PDF file:New window opens(68KB)
February 1, 2011
Notice of revisions to the Appendix to the Fiscal 2010 Consolidated Financial StatementsPDF file:New window opens(160KB)
January 28, 2011
Kyowa Hakko Kirin Fiscal 2010 Results (Fiscal year to December 31,2010)PDF file:New window opens(1372KB)
January 28, 2011
Consolidated Financial Summary Fiscal 2010PDF file:New window opens(296KB)
January 28, 2011
(Revised Edition) Appendix to the Fiscal 2010 Consolidated Financial StatementsPDF file:New window opens(156KB)
January 28, 2011
(Revised Edition) Kyowa Hakko Kirin Fiscal 2010 Sales up 1.7%, Operating income up 46.8%PDF file:New window opens(64KB)

Get Adobe® Reader®You need Adobe® Reader® to view these documents.
Download Adobe® Reader® of Adobe Systems here.



To Page Top